NeuroScientific Biopharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
NeuroScientific Biopharmaceuticals has a total shareholder equity of A$5.4M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$5.4M and A$85.7K respectively. NeuroScientific Biopharmaceuticals's EBIT is A$155.3K making its interest coverage ratio -0.9. It has cash and short-term investments of A$5.0M.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | -0.9x |
| Cash | AU$4.95m |
| Equity | AU$5.35m |
| Total liabilities | AU$85.68k |
| Total assets | AU$5.44m |
Recent financial health updates
Is NeuroScientific Biopharmaceuticals (ASX:NSB) In A Good Position To Deliver On Growth Plans?
May 25
Companies Like NeuroScientific Biopharmaceuticals (ASX:NSB) Are In A Position To Invest In Growth
Jan 27NeuroScientific Biopharmaceuticals (ASX:NSB) Is In A Good Position To Deliver On Growth Plans
Oct 07Companies Like NeuroScientific Biopharmaceuticals (ASX:NSB) Can Afford To Invest In Growth
Jun 23Companies Like NeuroScientific Biopharmaceuticals (ASX:NSB) Are In A Position To Invest In Growth
Mar 10We're Hopeful That NeuroScientific Biopharmaceuticals (ASX:NSB) Will Use Its Cash Wisely
Nov 18Recent updates
Is NeuroScientific Biopharmaceuticals (ASX:NSB) In A Good Position To Deliver On Growth Plans?
May 25Companies Like NeuroScientific Biopharmaceuticals (ASX:NSB) Are In A Position To Invest In Growth
Jan 27NeuroScientific Biopharmaceuticals (ASX:NSB) Is In A Good Position To Deliver On Growth Plans
Oct 07Companies Like NeuroScientific Biopharmaceuticals (ASX:NSB) Can Afford To Invest In Growth
Jun 23Companies Like NeuroScientific Biopharmaceuticals (ASX:NSB) Are In A Position To Invest In Growth
Mar 10We're Hopeful That NeuroScientific Biopharmaceuticals (ASX:NSB) Will Use Its Cash Wisely
Nov 18Financial Position Analysis
Short Term Liabilities: NSB's short term assets (A$5.0M) exceed its short term liabilities (A$85.7K).
Long Term Liabilities: NSB has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: NSB is debt free.
Reducing Debt: NSB had no debt 5 years ago.
Debt Coverage: NSB has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: NSB has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 06:28 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NeuroScientific Biopharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|